코다이그노스틱스(CODX)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.99 (+5.20%), 시가총액 $0.00B, 52주 최저~최고 $0.17 ~ $6.19.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools f
코다이그노스틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
코다이그노스틱스의 현재 주가는 $0.99 (+5.20%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
코다이그노스틱스의 시가총액은 약 $0.00B입니다.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei